Vishal Medatia

Novartis Pharmaceuticals Corporation
East Hanover, NJ, USA

Presentation(s):

• 217: COSENTYX® (secukinumab) Joint Decision Making

  Monday, November 13, 2023
  11:30 AM – 12:15 PM PT

  Disclosure information not submitted.